Carregant...
Predictive factors for long‐term responders of pemetrexed maintenance treatment in non‐small cell lung cancer
BACKGROUND: We determined the clinical characteristics and predictive factors of long‐term response to pemetrexed maintenance therapy as first‐line treatment for non‐small cell lung cancer (NSCLC). METHODS: A total of 950 advanced NSCLC patients received pemetrexed (500 mg/m(2)) plus cisplatin (60 m...
Guardat en:
| Publicat a: | Thorac Cancer |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons Australia, Ltd
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6449266/ https://ncbi.nlm.nih.gov/pubmed/30864258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13033 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|